Trials / Conditions / Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified
Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified
3 registered clinical trials studyying Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Synd NCT07468916 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Recruiting | Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic S NCT05549661 | Mayo Clinic | Phase 1 |
| Terminated | Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms Wit NCT05005182 | Mayo Clinic | Phase 2 |